Erlin-2 antibody
Principal name
Erlin-2 antibody
Alternative names for Erlin-2 antibody
SPFH domain-containing protein 2, Erlin 2, C8orf2, SPFH2, PRO5003, PRO9924, Endoplasmic reticulum lipid raft-associated protein 2, Stomatin-prohibitin-flotillin-HflC/K domain-containing protein 2
Ncbi ID
9606, NP_009106, NP_001003790.1, NP_705820.1, NM_153592, NM_007175, NM_001003790
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), Paraffin Sections (P)
Background of Erlin-2 antibody
- Kit Component:
- - KN305349G1, Erlin2 gRNA vector 1 in pCas-Guide vector
- KN305349G2, Erlin2 gRNA vector 2 in pCas-Guide vector
- KN305349D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Garcia MJ, Pole JC, Chin SF, Teschendorff A, Naderi A, Ozdag H, Vias M, Kranjac T, Subkhankulova T, Paish C, Ellis I, Brenton JD, Edwards PA, Caldas C. A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes. Oncogene. 2005 Aug 4;24(33):5235-45.
ERLIN2 polyclonal antibody ( Cat # PAB6852 ) staining ( 1 µg/ml ) of human breast lysate ( RIPA buffer, 30 µg total protein per lane ) . Primary incubated for 1 hour. Detected by western blot using chemiluminescence.
Human Fetal Heart; Host:Rabbit. Target Name:ERLIN2. Sample Tissue:Human Fetal Heart. Antibody Dilution: 1.0ug/ml.; ERLIN2 antibody - middle region (ARP58461_P050) in Human Fetal Heart cells using Western Blot
Human 721_B; Host:Rabbit. Target Name:ERLIN2. Sample Tissue:721_B. Antibody Dilution: 1.0ug/ml. ERLIN2 is strongly supported by BioGPS gene expression data to be expressed in Human 721_B cells.; ERLIN2 antibody - middle region (ARP58461_P050) in Human 721_B cells using Western Blot
Human Adult Placenta; Host:Rabbit. Target Name:ERLIN2. Sample Tissue:Human Adult Placenta. Antibody Dilution: 1.0ug/ml.; ERLIN2 antibody - middle region (ARP58461_P050) in Human Adult Placenta cells using Western Blot
Human Fetal Lung; Host:Rabbit. Target Name:ERLIN2. Sample Tissue:Human Fetal Lung. Antibody Dilution: 1.0ug/ml.; ERLIN2 antibody - middle region (ARP58461_P050) in Human Fetal Lung cells using Western Blot
Human 293T; WB Suggested Anti-ERLIN2 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:62500. Positive Control: 293T cell lysate.. ERLIN2 is strongly supported by BioGPS gene expression data to be expressed in HEK293T.; ERLIN2 antibody - middle region (ARP58461_P050) in Human 293T cells using Western Blot
Human HeLa, AT3; ERLIN2 antibody - middle region (ARP58461_P050) validated by WB using HeLa, aT3 cells at 1:200 / 1:1000.; ERLIN2 antibody - middle region (ARP58461_P050) in Human HeLa, AT3 cells using Western Blot
Human Fetal Brain; Host:Rabbit. Target Name:ERLIN2. Sample Tissue:Human Fetal Brain. Antibody Dilution: 1.0ug/ml.; ERLIN2 antibody - middle region (ARP58461_P050) in Human Fetal Brain cells using Western Blot
Immunohistochemistry: SPFH2 Antibody - Strong cytoplasmic staining, most likely located in the endoplasmatic reticulum, was observed in a majority of normal and malignant tissues. Many cases of non-Hodgkin's lymphoma were negative. Image and statement courtesy of the Human Protein Atlas (HPA).
Western Blot: SPFH2 Antibody - Samples: Lane 1, Marker: 250, 130, 95, 72, 55, 36, 28, 17, 11 Lane 2, RT-4 Lane 3, U-251MG sp Lane 4, Human Plasma Lane 5, Liver Lane 6, Tonsil, Target weight: 38, 17 (splice variants) Validation score: 2 Validation description: Supportive - Band of predicted size in kDa (+/-20%) with additional bands present.
ELISA: SPFH2 Antibody
TA303052 staining (1µg/ml) of Human Breast lysate (RIPA buffer, 30µg total protein per lane). Primary incubated for 1 hour. Detected by western blot using chemiluminescence.
Sample(30 ug of whole cell lysate). A:HeLa S3. 12% SDS PAGE. TA308471 diluted at 1:500
Immunohistochemical analysis of paraffin-embedded endo mitral OVCA, using ERLIN2(TA308471) antibody at 1:100 dilution.
WB Suggested Anti-ERLIN2 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:62500; Positive Control: 293T cell lysate.ERLIN2 is strongly supported by BioGPS gene expression data to be expressed in HEK293T
ERLIN2 antibody - middle region validated by WB using HeLa, aT3 cells at 1:200 / 1:1000.
Host:Rabbit; Target Name:ERLIN2; Sample Tissue:Human Adult Placenta; Antibody Dilution: 1.0 ug/ml
Host:Rabbit; Target Name:ERLIN2; Sample Tissue:Human Fetal Lung; Antibody Dilution: 1.0 ug/ml
Host:Rabbit; Target Name:ERLIN2; Sample Tissue:Human Fetal Heart; Antibody Dilution: 1.0 ug/ml
Host:Rabbit; Target Name:ERLIN2; Sample Tissue:Human Fetal Brain; Antibody Dilution: 1.0 ug/ml
Host:Rabbit; Target Name:ERLIN2; Sample Tissue:721_B; Antibody Dilution: 1.0 ug/mlERLIN2 is strongly supported by BioGPS gene expression data to be expressed in Human 721_B cells
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA303052 | Erlin-2 (Isoform 1) (C-term) antibody |
||||||
| Goat Polyclonal Antibody against ERLIN2 | |||||||
 |
Goat | Aff - Purified | Hu, Rt | WB |
0.1 mg /
€360.00
|
||
| OriGene Technologies, Inc. | |||||||
| TA308471 | Erlin-2 antibody |
||||||
| Rabbit polyclonal antibody to ERLIN2 (ER lipid raft associated 2) | |||||||
 |
Rabbit | IgG | Aff - Purified | Hu | P, WB |
0.1 ml /
€415.00
|
|
| OriGene Technologies, Inc. | |||||||
 +1 additional image |
|||||||
| TA590556 | Erlin-2 antibody |
||||||
| Rabbit Polyclonal SPFH2 Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu | E, P, WB |
0.1 mg /
€409.00
|
|
| OriGene Technologies, Inc. | |||||||
| +2 additional images |
|||||||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR205094L2V | Lenti ORF particles, Erlin2 (GFP-tagged) - Mouse ER lipid raft associated 2 (Erlin2), 200 uL, >10^7 TU/mL |
|
 |
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR205094L1V | Lenti ORF particles, Erlin2 (Myc-DDK-tagged) - Mouse ER lipid raft associated 2 (Erlin2), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||